Research Topics
| J H GreistSummaryAffiliation: Healthcare Technology Systems Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Factors contributing to failed trials of new agents: can technology prevent some problems?John H Greist
Healthcare Technology Systems, Inc, 7617 Mineral Point, Suite 300, Madison, WI 53717, USA
J Clin Psychiatry 63:8-13. 2002..This article describes methodological factors that can confound study outcomes and discusses the potential for interactive voice response (IVR) technology to address some of these problems...
Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a controlJohn H Greist
Healthcare Technology Systems, and the University of Wisconsin, Madison, 53717, USA
J Clin Psychiatry 63:138-45. 2002..This study compared the value of computer-guided behavior therapy value with that of clinician-guided behavior therapy and systematic relaxation as a control treatment...
Lay person-based screening for early detection of Alzheimer's disease: development and validation of an instrumentJ C Mundt
Healthcare Technology Systems, LLC, Madison, Wisconsin 53717, USA
J Gerontol B Psychol Sci Soc Sci 55:P163-70. 2000....
Social anxiety disorder: an unrecognized problem in primary careD J Katzelnick
Madison Institute of Medicine, Inc, and Healthcare Technology Systems, LLC, WI 53717, USA
J Clin Psychiatry 62:11-5; discussion 15-6. 2001..There is a need for further study and greater awareness among primary health care providers about the prevalence and treatment of social anxiety disorder...
Impact of generalized social anxiety disorder in managed careD J Katzelnick
Madison Institute of Medicine, UNC, Madison, WI 53717, USA
Am J Psychiatry 158:1999-2007. 2001..The authors determined the costs associated with generalized social anxiety disorder in a managed care setting...
Meeting the need for public education about dementiaJ C Mundt
Healthcare Technology Systems, Inc, Madison, Wisconsin 53717, USA
Alzheimer Dis Assoc Disord 15:26-30. 2001..Such IVR technology may provide a cost-effective bridge to the "digital divide" existing among elderly, lower socioeconomic status, and rural populations underrepresented as computer and Internet users...
Computer-automated dementia screening using a touch-tone telephoneJ C Mundt
Healthcare Technology Systems Inc, 7617 Mineral Point Rd, Suite 300, Madison, WI 53717, USA
Arch Intern Med 161:2481-7. 2001..This study investigated the sensitivity and specificity of a computer-automated telephone system to evaluate cognitive impairment in elderly callers to identify signs of early dementia...
St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind studyKenneth A Kobak
Dean Foundation for Health Research and Education, Middleton, Wisconsin 53562, USA
Int Clin Psychopharmacol 20:299-304. 2005..9%) and placebo (16.7%) (P=0.905). Only one patient from each group discontinued due to adverse events [sinus infection (St John's wort); confusion (placebo)]. The results fail to support the efficacy of St John's wort for OCD...
The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trialTerence A Ketter
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, Calif, USA
J Clin Psychiatry 67:400-6. 2006..This study assessed the impact of specific instructions designed to decrease risk of dermatologic reactions, including nonserious rash, during initiation of and early treatment with lamotrigine in patients with bipolar I disorder...
An examination of 26,168 Hamilton Depression Rating Scale scores administered via interactive voice response across 17 randomized clinical trialsHeidi K Moore
Healthcare Technology Systems, Inc Madison, WI 53717, USA
J Clin Psychopharmacol 26:321-4. 2006....
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority studyAndrew A Nierenberg
Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA, USA
Curr Med Res Opin 23:401-16. 2007..The purpose of this non-inferiority study was to compare the speed of onset of antidepressant efficacy for duloxetine (a dual serotonin and norepinephrine reuptake inhibitor) and escitalopram (a selective serotonin reuptake inhibitor)...
Assessing the onset of antidepressant-induced sexual dysfunction using interactive voice response technologyJudith A Dunn
Pfizer Global Research and Development, New London, Conn, USA
J Clin Psychiatry 68:525-32. 2007..The current study was designed to evaluate the validity of obtaining CSFQ data using interactive voice response (IVR) technology...
Cost-effectiveness of computer-aided behaviour therapy for obsessive-compulsive disorderPaul McCrone
Psychother Psychosom 76:249-50. 2007
Telephonic Remote Evaluation of Neuropsychological Deficits (TREND): longitudinal monitoring of elderly community-dwelling volunteers using touch-tone telephonesJames C Mundt
Healthcare Technology Systems, Inc, Madison, WI 53717, USA
Alzheimer Dis Assoc Disord 21:218-24. 2007..Such assessments might benefit routine clinical care and large-scale, longitudinal research in the future, but will require additional research over longer periods...
A novel interactive voice response (IVR) system for dementia screening, education, and referral: one-year summaryJames C Mundt
Healthcare Technology Systems, Inc, Madison, Wisconsin 53717, USA
Alzheimer Dis Assoc Disord 19:143-7. 2005..Overall, the 1-year results support the need for accessible and anonymous resources for individuals concerned about dementia...
A comparison of initial duloxetine dosing strategies in patients with major depressive disorderVirgil G Whitmyer
Lilly Research Laboratories, Eli Lilly and Co, Indianapolis, Ind, USA
J Clin Psychiatry 68:1921-30. 2007..To compare the effects of starting doses of duloxetine taken with or without food on tolerability and efficacy in patients with major depressive disorder (MDD)...
WCA recommendations for the long-term treatment of social phobiaMichael Van Ameringen
Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, Ontario, Canada
CNS Spectr 8:40-52. 2003..In light of the chronicity and disability associated with social phobia, as well as the high relapse rate after short-term therapy, it is recommended that effective treatment be continued for at least 12 months...
WCA recommendations for the long-term treatment of panic disorderMark H Pollack
Division of Psychiatry, Huddinge University Hospital, Stockholm, Sweden
CNS Spectr 8:17-30. 2003..Long-term efficacy and ease of use are important considerations in treatment selection, as maintenance treatment is recommended for at least 12-24 months, and in some cases, indefinitely...
WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adultsJohn H Greist
Healthcare Technology Systems, Inc, Madison, Wisconsin 53717, USA
CNS Spectr 8:7-16. 2003..Further, pharmacotherapy for a minimum of 1-2 years is recommended before very gradual withdrawal may be considered...
A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorderEric Hollander
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
J Clin Psychiatry 64:640-7. 2003....
The Work and Social Adjustment Scale: a simple measure of impairment in functioningJames C Mundt
Healthcare Technology Systems Inc, 7617 Mineral Point Road, Suite 300, Madison, WI 53717, USA
Br J Psychiatry 180:461-4. 2002..CONCLUSIONS: The WSAS is a simple, reliable and valid measure of impaired functioning. It is a sensitive and useful outcome measure offering the potential for readily interpretable comparisons across studies and disorders...
Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trialDavid Mataix-Cols
Department of Psychiatry, Imperial College School of Medicine, London, UK
Psychother Psychosom 71:255-62. 2002..Existing treatments need to be refined and/or new treatments developed to improve these patients' adherence and response to treatment...
Fluoxetine in social phobia: a double-blind, placebo-controlled pilot studyKenneth A Kobak
Dean Foundation for Health, Research and Education, Middleton, Wisconsin, USA
J Clin Psychopharmacol 22:257-62. 2002..Fluoxetine failed to separate from placebo in this trial. It is unknown whether a larger dose for longer duration would have yielded separation from placebo. A higher than usual placebo response rate was found...
A pilot study of an electronic, adolescent version of the quick inventory of depressive symptomatologyHeidi K Moore
Healthcare Technology Systems, Inc, Madison, WI 53717, USA
J Clin Psychiatry 68:1436-40. 2007..An adolescent version of the QIDS (QIDS-A-IVR) was created using speaker-independent voice recognition technology. An informant version, QIDS-P-IVR, collects ratings from parents or other knowledgeable adults...
Is it easier to find what you are looking for if you think you know what it looks like?James C Mundt
J Clin Psychopharmacol 27:121-5. 2007
Immediate switching of antidepressant therapy: results from a clinical trial of duloxetineMadelaine M Wohlreich
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA
Ann Clin Psychiatry 17:259-68. 2005..We examined the efficacy and tolerability associated with a switch from a selective serotonin reuptake inhibitor (SSRI) or venlafaxine to duloxetine...
Validation of an IVRS version of the MADRSJames C Mundt
Healthcare Technology Systems, Inc, 7617 Mineral Point Road, Madison, WI 53717, USA
J Psychiatr Res 40:243-6. 2006..Clinicians rated the severity of subjects' sadness and pessimistic thoughts lower than subjects self-report. The data obtained in this pilot study provide support for the equivalence between the clinician and IVR versions of the MADRS...
Research Grants
- Facilitating Dementia Screening, Education and ReferralJohn Greist; Fiscal Year: 2003....
